Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPASS: GnRH-analog vs Placebo, Estrogen, and Testosterone in Postmenopausal Women
NCT07254429Phase 2Recruiting
- Start
- Oct 2025
- Primary completion
- Dec 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triptorelin in postmenopausal osteoporosis, vasomotor symptoms of menopause (VMS). Started Oct 2025; status: recruiting.
02
Drugs
triptorelin
03
Conditions
postmenopausal osteoporosisvasomotor symptoms of menopause (VMS)
Beyond the preview
Go deeper on NCT07254429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07254429.